To gain insight into regions of the platelet GPIIb-Ma complex involved in receptor biogenesis and function, we examined the biochemical properties of a defective GPIIb-Ia complex from patient suffering from type II Glanzmann
Introduction
In 1918, Glanzmann described a bleeding disorder that he termed "thrombasthenie," meaning "weak platelets," manifested by normal platelet counts but abnormal clot retraction (1) . Platelets from thrombasthenic patients could not spread onto a glass surface (2) nor could they aggregate, indicating that the platelets were functionally defective (3, 4) . Glanzmann thrombasthenia (GT)' is now recognized as a rare autosomal recessive platelet disorder that is clinically characterized by lifelong mucocutaneous bleeding (5) . This disease occurs in a small fraction of the population; however, a high incidence persists in confined geographical areas within certain ethnic groups in which marriage is practiced among descendants of a common ancestor (5) . Thrombasthenic platelets fail to bind fibrinogen and aggregate after stimulation by physiologic agonists such as ADP, thrombin, epinephrine, or collagen (6) .
GT has been subclassified based upon platelet intracellular fibrinogen content and the ability of platelets to retract a fibrin clot (7) . Type I patients lack platelet fibrinogen and clot retraction, whereas type H thrombasthenic platelets contain appreciable levels of platelet fibrinogen and maintain some clot retraction capability. The basis of GT lies within an abnormality of the genes that encode the major receptor for fibrinogen, glycoproteins (GP)IIb-Iia. GPIIb and 111a are specifically decreased in thrombasthenic versus normal platelets (8) . Type I GT patients lack detectable levels of GPHb-IHa, whereas type II GT platelets express moderate (10-25%) levels of GPI1b-HIa (5) . Variant forms of thrombasthenia have also been described with increasing frequency and are characterized as possessing normal to near-normal levels of a dysfunctional form of GPIIb-HIa present on the cell surface (9) (10) (11) (12) . Platelets from type I, type H, and variant forms of GT are functionally indistinguishable in that all fail to bind the adhesive ligand fibrinogen and selfassociate (aggregate) in response to platelet activation.
GPIIb-Ia (a0,83) is a member of the widely known receptor family of integrins, which mediate the adhesion of cells to each other and to the extracellular matrix (13) . Glycoproteins HIb (145,000 Mr) and lila (95,000 Mr) associate in a noncovalent, calcium-dependent manner to form a complex that is present exclusively on platelets. The complex primarily mediates the interaction of activated platelets with fibrinogen during hemostasis; however, GPIIb-hIa is also known to associate with other adhesive ligands including von Willebrand factor, fibronectin, and collagen (14, 15) . Study of GPIIb-HIa complex biosynthesis within cultured human leukemic and megakaryocytic cell lines has led to a better understanding of key steps that take place during the synthesis, assembly, and processing of integrins (16) (17) (18) . GPI~b and GPHIa subunits are synthesized within the rough endoplasmic reticulum as single-chain molecules and assembled into a pre-GPIIb-Iila complex. Oligosaccharides, consisting mainly of high-mannose sugar moieties, are added to both GPIIb and GPHIa within the endoplasmic reticulum, representing 15 and 18% of each subunit's molec-ular mass, respectively (19) . Subsequent to complex assembly, pre-GPIIb-IIIa is transported to the Golgi apparatus, where a number of posttranslational modifications occur. Pre-GPIIb is cleaved at amino acid 859 into a heavy (125,000 Mr) and light (23,000 Mr) chain (20) that remains covalently linked by a single disulfide bond formed by residues CYS826-CYS880 (21) .
The high-mannose sugars of GPIIb are converted to complex carbohydrates within the Golgi apparatus; however, most of the sugar residues on GPIIIa remain of the high-mannose type. After these processing events within the Golgi apparatus, the mature GPIIb-IIIa complex is then rapidly transported to the cell surface.
Analysis of molecular genetic defects present in GPIIb or GPIIa of patients with GT has previously proved to be beneficial toward defining precise structural domains of integrins that play a role in the biosynthesis, subunit association, maturation, expression, and function. Thus, two regions which play a role in maturation of GPHIIb-Ia have been reported in GPIIb (22, 23) , three separate mutations in GPIHa have helped to further define regions involved in ligand binding and stability of the GPIIb-IIIa complex (24) (25) (26) , and a single amino acid substitution within the cytoplasmic domain of GPIIIa helped to define a region involved in receptor activation (27) . One of the purposes of this investigation was to continue to identify such regions by examining the molecular basis of naturally occurring inherited defects that result in defective surface expression and or function of integrin subunits. In this paper, we will demonstrate that a single amino acid mutation between the second and third calcium-binding domains of the integrin a subunit GPHb slows intracellular trafficking to the cell surface, resulting in type II GT. Characterization of the biosynthetic blockade induced by this naturally occurring amino acid substitution has revealed regions of GPIIb that appear to play important structural roles in the maturation and subunit association of integrin complexes.
Methods
Patient studies. The propositus is a 14-yr-old German female, the product of a consanguineous marriage, who presented with severe hemorrhage after a tonsillectomy. The Plus® flow cytometer (Becton Dickinson Mountain View, CA) as previously described (32) , and data were analyzed using Becton Dickinson Lysys software.
Platelet membrane glycoprotein analysis. Detergent platelet lysates from both normal and thrombasthenic individuals were prepared as previously described (33) , added to the wells of a 5-15% gradient SDS-polyacrylamide gel, and electrophoresed under reducing conditions. Platelet proteins were transferred to an Immobilon-P membrane (Millipore Corp., Bedford, MA), which was then incubated with rabbit polyclonal antiserum directed against GPIIb (5 pg/ml) or GPIHa (20 pg/ml). Bound antibodies were detected by incubation of the membrane with goat anti-rabbit IgG conjugated to alkaline phosphatase and visualized by development with the nitro blue tetrazolium/5-bromo4-chloro-3-indolyl phosphate substrate pair (Sigma Immunochemical, St. Louis, MO).
Amplification of platelet messenger mRNA. Platelet messenger mRNA was isolated from 50 ml of whole blood and reverse transcribed into cDNA with a GPIlb-specific antisense oligonucleotide primer and Moloney murine leukemia virus reverse transcriptase (Life Technologies, Inc., Gaithersburg, MD) using previously described methods (32 Cos-7 cells were biotin-surface labeled as described previously (23) .
After biotinylation, cells were solubilized in Triton X-100 and immunoprecipitated as described above. Immunoprecipitates were subjected to SDS-PAGE and transferred onto Immobilon membranes (Millipore Corp.), which were then incubated in a 1:4,000 dilution of streptavidinhorseradish peroxidase (Amersham, Arlington Heights, IL) for 1 h at room temperature. After washing, blots were incubated in detection reagents 1 and 2 (ECG kit; Amersham) for 1 min and exposed to Hyperfilm (Amersham) for up to 3 min.
Results
GPIb-IIa content and function ofpatient KJ's platelets. Platelets from Glanzmann thrombasthenic patient KJ were examined by flow cytometry for the expression of GPIIb-IIIa (see Methods). Platelets were isolated and incubated with FITC-conjugated antibodies specific for GPIb (AP-1), GPIIIa (AP3), GPHb (Tab), or the GPIIb-IIIa complex (AP2) (Fig. 1) . Platelets from all individuals examined expressed similar levels of GPIb (Fig. 1, A and B. upper left); however, antibodies specific for GPIIb, GPIIIa, and the GPILb-Hla complex demonstrated that patient KJ expressed only 7-10% of the normal content of GPIIb-IIIa on the platelet surface. Her platelet GPIIb-IIIa surface expression was higher than that of type I GT patient KW (Fig. 1 A) , while her mother, EJ, expressed 55% GPHbII1a, consistent with her status as a carrier of thrombasthenia (Fig. 1 B) . Based upon these observations, we provisionally classified KJ as a type II thrombasthenic.
To confirm the type H Glanzmann phenotype, KJ's platelets were further examined for their ability to retract a fibrin clot. (Fig. 4) . This results in the transformation of Arg327 to His in the GPIIb polypeptide chain. Alignment of this region of GPIIb with all other known integrin a-subunits from Drosophila to humans revealed the presence of an arginine or glutamine at this relative position between the second and third cation binding domains of integrin a-subunits (Table I ). The substitution of histidine conserves a positive charge at this position, however an additional stearic constraint is placed upon the GPilb subunit which may have an effect on the processing or ligand binding capability of the GPIIb-Iila complex.
Effect of Arg327-+His substitution on biogenesis of the GPIIb-IIIa complex. To determine whether the Arg327-4His mutation of GPIIb represents a neutral polymorphism, or an altered structural region which is responsible for the reduced level of GPilb-IHIa on the platelet surface in patient KJ, an expression vector encoding the His327 form of GPIIb was constructed (see Methods) and cotransfected with a vector encoding wild-type GPIia into Cos-7 cells. Transfected Cos-7 cells were surface labeled with biotin 72 h after transfection and then subjected to immunoprecipitation analysis using antibodies directed against glycoproteins IIb and mia. As shown in Fig. 5 Figure 3 . Semiquantitative immunoblot analysis of platelet GPIIb-Illa content. Detergent lysates of whole platelets were prepared from a normal control, the patient's mother (EJ), and the patient (KJ). jsg total protein was loaded onto a 5-15% PAGE gel and electrophoresed under reducing conditions. After transfer to Immobilon membranes, the blot was incubated with a mixture of rabbit polyclonal antibodies specific for GPI~b (5 jig/ml) and GPIIIa (20 jig/ml). Immunoreactive bands were detected as described in Methods. The band at 190,000 Mr is thought to represent GPIila dimer and is most prominent in the patient lysate. From these data, patient KJ appears to express 10-15% of GPIIIa, while his mother's platelets contain 50-60% levels. The absence of GPIIb after detergent solubilization differs from the results seen by flow cytometric analysis of intact platelets (Fig. 1) AP3. As shown in Fig. 6 , both the precursor and mature forms of wild-type Arg327 GPIIb coprecipitated, confirming their association with GPIIa. The presence of mature Arg327 GPIIb in the immunoprecipitate is indicative that some of the complex had proceeded to the Golgi apparatus, where cleavage of proGPIIb into heavy and light chains has taken place. The His327 form of pro-GPIIb also associated with GPIIIa, as evidenced by the coimmunoprecipitation of both subunits by AP3, but the immunoprecipitates contained reduced to nondetectable levels of the mature His327 GPHb heavy chain, demonstrating that the Arg327-+His mutation of GPIIb inhibited the kinetics of processing of this receptor as it traffics to the cell surface. Role ofthe calcium-binding domains in GPIIb-lla association. Patient KJ represents the third Glanzmann patient to be characterized as having a missense mutation within or immediately proximal to one of the calcium-binding domains of GPIIb (22, 23) . Interestingly, despite the importance ascribed to calcium ions in supporting the formation and integrity of the GPIhb-Ia complex (34) (35) (36) (37) , subunit association appears to be unaffected by mutations in either the first (22), second/third (this paper), or fourth calcium-binding domains of GPIlb (23) . To further examine the role of the GPIIb calcium-binding domains in subunit association, we constructed recombinant GPIIb fragments that contained the signal peptide and amino terminus, but ended before the first (residues 1-243), second (residues 1-296), or third (residues 1-364) calcium-binding domains. GPIIb with GPIIa. Eukaryotic expression vectors encoding GPIIb fragments ending before the first (amino acids 1-243), second (residues 1-296), and third (residues 1-364) calcium-binding domains were constructed and cotransfected with a vector encoding full length GPIIIa into Cos-7 cells. Newly synthesized proteins were metabolically labeled with [35S]methionine, immunoprecipitated with a polyclonal antibody directed against GPIIb, and analyzed by SDS-PAGE and autoradiography under reducing conditions. Coprecipitation of GPHIa by the GPIIbspecific polyclonal antibody indicates that association between GPIIb and GPHIa has taken place. Vector without insert (Mock), GPIIa transfected alone, and full length GP1Ib transfected alone served as controls for antibody specificity. Note that GPIIa was coprecipitated with each fragment of GPIIb (1-243, 1-296, 1-364). Fragments 1-243, 1-296, and 1-364 contain 0, 1, and 2 methionines, respectively, which are available to metabolic label; therefore the GPIIb fragments are detected at different intensities. Coprecipitation of the GPIIb fragments was also found using antibodies directed against GPIIIa (not shown). Molecular mass markers are to the left in kilodaltons.-newly synthesized proteins were metabolically labeled with
[31S]methionine for 9 h and immunoprecipitated with a polyclonal antibody directed against GPIIb. As shown in Fig. 7 , when full length GPIIb was cotransfected with GPIIIa, both proteins were immunoprecipitated by the GPIlb-specific antibody, indicating that subunit association between GPIIb and GPIia had taken place. Somewhat unexpectedly, GPIHa was also coprecipitated with each of the truncated fragments of GPIIb, including the one that ended before the first calciumbinding domain. Fragments 1-243, 1-296, and 1-364 contain 0, 1, and 2 methionines, respectively, that are available to metabolic label; therefore, the GPI~b fragments are detected at different intensities. Nonetheless, nearly equal amounts of GPIIla were immunoprecipitated in each instance, indicating that each GPHb fragment quantitatively associated with GPIIIa. These data indicate that calcium-binding domains may not be necessary for initial subunit association of GPIIb with GPIIIa and may in part explain our observations that a single amino mutation between the second and third calcium-binding domains did not affect formation of the pro-GPilb-GPHIa complex.
Discussion
We report the first characterization of a molecular genetic defect resulting in type II GT. Classification as type II GT was a result of detecting > 5% GPIlb-iHIa on KJ's platelets by flow cytometry (Fig. 1) and due to the ability of KJ's platelets to partially retract a fibrin clot (Fig. 2) . Western blot analysis of KJ's platelet protein revealed a substantial reduction in the level of GPIIb and GPIila (Fig. 3) , with GPIila present in slightly greater amounts, presumably due to its additional association with the vitronectin receptor a-subunit (avf33). Based upon these results, we examined the nucleotide sequence of the mRNA transcript encoding GPilb and found a single G1074A nucleotide substitution that resulted in an Arg327-.His amino acid substitution (Fig. 4) between the second and third calciumbinding domains of GPIIb. The conformational constraints placed upon this region of GPIlb by this mutation conceivably could have multiple effects on receptor function in terms of subunit stability, calcium-mediated subunit association, or ligand binding ability. Interestingly, residue 327 is positioned only 13 amino acids away from the region on GPIIb shown to interact with the y-chain dodecapeptide of fibrinogen (38) . Moreover, the presence of an arginine at this location is highly conserved among other integrin a-subunits (Table I) , suggesting an important role for this residue in integrin structure or function.
We determined that the Arg327-His amino acid substitution in GPHb was not a naturally occurring neutral polymorphism of GPHb, but instead was the defect that resulted in GT in patient KJ. Mammalian expression vectors encoding GPiHIa and the His327 form of GPHb were constructed and cotransfected into Cos-7 cells. Biotin-labeling of cell surface proteins followed by immunoprecipitation analysis demonstrated that substitution of a single histidine residue resulted in a highly reduced level of GPlb-Iila on the Cos-7 cell surface (Fig. 5) (Fig. 2) .
It has been recognized for more than 10 yr that the GPI~b-IIa complex requires the presence of calcium to maintain subunit association (34) (35) (36) (37) , and it has recently been shown that optimal fibrinogen binding occurs when each of the four calcium-binding sites are occupied (40) . The precise relationship, if any, between the role of calcium in maintaining subunit association versus its role in mediating ligand binding to the complex is as yet unclear. The opportunity to analyze the effects of the three unique mutations described above that result in GT, each proximal to one of the calcium-binding domains of GPIIb, has enabled us to begin to make some observations regarding the role of these domains in integrin biogenesis and function. In each case, substitution for a highly conserved amino acid within or proximal to a calcium-binding domain did not affect association of pro-GPIIb with GPHIa, though downstream effects on maturation of the GPIIb-IHa complex ultimately led to the thrombasthenic phenotype. These data suggest that a region(s) outside the calcium-binding domain may participate, at least early on, in subunit association. Interestingly Rosa and McEver (18) have already shown that the pro-GPIIb-Ila complex is less easily dissociable by EDTA treatment than is mature GPIIb-llIa, supporting the notion that the association of proGPIIb with GPIIa that occurs during early biogenesis may be calcium independent.
To test this hypothesis, we constructed three overlapping amino terminal fragments of GPIIb containing none, one, or two calcium-binding domains and examined their interaction and association with GPHIa. All three fragments, including one that contained no calcium-binding domains (residues 1-243), were able to associate with GPIIa (Fig. 7) . These data demonstrate that the calcium-binding domains of GPIIb are not necessary for initial association of GPIIb with GPIIIa and provide a possible explanation for the observation that amino acid substitutions at or near calcium-binding domains of GPIIb do not affect formation of the pro-GPIIb-GPHIa complex.
Several other investigators have examined the structural requirements for integrin subunit association. Lam et al. (41) used mild reduction to dissociate the heavy chain of GPIIb from the light chain and showed that the heavy chain was still complexed with GPIHa. Calvete and colleagues (42) used limited proteolysis of isolated heterodimers followed by proteinchemical analysis of the resulting peptide fragments to identify a number of putative contact sites between GPIIb and GPIIa. Interestingly, these authors were able to deduce that three regions of the GPIIb heavy chain were involved in intersubunit interactions: amino acids 486-553, 696-734, and 780-814. They also proposed that residues 901-946, located within the GPIIb light chain, formed a contact site with GPLIa. They found no evidence that the amino terminus of GPIIb interacted with GPIHa, however, most probably due to the fact that this region is highly susceptible to proteolytic degradation, and is therefore not amenable to analysis using their approach. Finally, Wippler et al. (43) constructed and expressed in baculovirus truncated subunits consisting of GPHb 1-874 and GPIIa 1-469 and showed that these residues were sufficient to form a heterodimer complex and bind ligand. Our studies further showing that subunit association may require only residues help to further define the domains involved in noncovalent intersubunit interactions and provide an additional example of the unique contributions that can be provided through detailed examination of the biochemical consequences of naturally occurring inherited platelet defects.
